We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+2.71%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$769M
AUM Growth
+$65.2M
Cap. Flow
+$56.1M
Cap. Flow %
7.29%
Top 10 Hldgs %
20.71%
Holding
282
New
36
Increased
134
Reduced
24
Closed
29

Top Buys

Rank Stock Value
1
DT icon
Dynatrace
DT
+$10.8M
2
CRWD icon
CrowdStrike
CRWD
+$10.4M
3
ZEN
ZENDESK INC
ZEN
+$10.2M
4
DOCU
DocuSign
DOCU
+$9.95M
5
CRM icon
Salesforce
CRM
+$8.04M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$11.7M
2
ANSS
Ansys
ANSS
+$9.54M
3
QRVO icon
Qorvo
QRVO
+$9.26M
4
SPGI icon
S&P Global
SPGI
+$8.81M
5
MKTX icon
MarketAxess Holdings
MKTX
+$6.51M

Sector Composition

Rank Sector Weight
1 Technology 37.72%
2 Healthcare 10.52%
3 Financials 7.64%
4 Industrials 7.46%
5 Communication Services 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDSI
126
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.5M 0.2%
416,722
+37,120
+10% +$140K
MODN
127
DELISTED
MODEL N, INC.
MODN
$1.43M 0.19%
42,774
+4,077
+11% +$138K
CXDO icon
128
Crexendo
CXDO
$215M
$1.43M 0.19%
239,011
+22,337
+10% +$134K
MANT
129
DELISTED
Mantech International Corp
MANT
$1.41M 0.18%
18,614
+1,945
+12% +$159K
LUV icon
130
Southwest Airlines
LUV
$22.1B
$1.38M 0.18%
26,799
+2,775
+12% +$140K
EGRX
131
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.34M 0.17%
24,000
– –
GNSS icon
132
Genasys
GNSS
$75.6M
$1.32M 0.17%
255,108
+27,505
+12% +$148K
MNTV
133
DELISTED
Momentive Global Inc. Common Stock
MNTV
$1.22M 0.16%
62,407
+8,923
+17% +$181K
VER
134
DELISTED
VEREIT, Inc.
VER
$1.17M 0.15%
25,937
– –
EGAN icon
135
eGain
EGAN
$176M
$1.15M 0.15%
112,726
– –
JPM icon
136
JPMorgan Chase
JPM
$939B
$968K 0.13%
5,916
– –
MRCY icon
137
Mercury Systems
MRCY
$6.2B
$963K 0.13%
20,315
+3,078
+18% +$171K
TMO icon
138
Thermo Fisher Scientific
TMO
$211B
$910K 0.12%
1,593
– –
WST icon
139
West Pharmaceutical
WST
$23.1B
$821K 0.11%
1,933
– –
BAC icon
140
Bank of America
BAC
$435B
$812K 0.11%
19,120
+25
+0.1% +$1.01K
AMD icon
141
Advanced Micro Devices
AMD
$851B
$776K 0.1%
7,546
-114,484
-94% -$11.7M
GH icon
142
Guardant Health
GH
$19.5B
$669K 0.09%
+5,350
New +$636K
PATH icon
143
UiPath
PATH
$5.62B
$661K 0.09%
+12,567
New +$761K
TER icon
144
Teradyne
TER
$54.8B
$640K 0.08%
5,861
+1,502
+34% +$183K
TTD icon
145
Trade Desk
TTD
$8.13B
$624K 0.08%
+8,883
New +$687K
COUP
146
DELISTED
Coupa Software Incorporated
COUP
$624K 0.08%
+2,847
New +$669K
GRMN
147
Garmin
GRMN
$46.9B
$618K 0.08%
3,974
– –
PLAN
148
DELISTED
Anaplan, Inc.
PLAN
$607K 0.08%
9,967
+2,340
+31% +$139K
ESTC icon
149
Elastic
ESTC
$6.1B
$581K 0.08%
+3,902
New +$600K
CVS icon
150
CVS Health
CVS
$137B
$580K 0.08%
6,833
– –
4 5
6
7 8

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2021 Portfolio in Review

As of Q3 2021, Stanley-Laman Group held 282 positions worth $769M, up 9.3% from $703M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Stanley-Laman Group deployed $56.1M of net new capital in Q3 2021, opening 36 new positions and adding to 134 existing holdings. Its largest new stake was ZENDESK INC: 79,007 shares worth $9.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $11.7M trimmed.

  • Stanley-Laman Group's largest Q3 2021 buy was ZENDESK INC: 79,007 shares worth $9.2M.
  • Stanley-Laman Group added most to Dynatrace in Q3 2021, an estimated $10.8M increase.
  • Stanley-Laman Group's biggest Q3 2021 reduction was Advanced Micro Devices, cutting an estimated $11.7M.
  • Stanley-Laman Group fully exited Ansys in Q3 2021, selling an estimated $9.54M.
  • Stanley-Laman Group's ten largest holdings make up 21% of its $769M portfolio in Q3 2021.
  • Stanley-Laman Group opened 36 new positions and closed 29 in Q3 2021.
  • Stanley-Laman Group's portfolio value rose 9.3% quarter-over-quarter to $769M.

Based on Stanley-Laman Group's 13F filing for Q3 2021, filed 3 Nov 2021.